Spectroscopic evidence for the presence of the cyclic hemiketal form of warfarin in aqueous solution: Consequences for bioavailability

Biochemical and Biophysical Research Communications

Volumn 407, Issue 2, 2011, Pages 318-320

  Rosengren, Annika M ^a,b   Karlsson, Björn C G ^a,b  

^a LINNAEUS UNIVERSITY   (Sweden)

^b SensiKal AB   (Sweden)

Author keywords

Anticoagulant; PH; Structural diversity; UV spectroscopy; Warfarin

Indexed keywords

ACETAL DERIVATIVE; ORGANIC SOLVENT; WARFARIN;

AQUEOUS SOLUTION; ARTICLE; DRUG BIOAVAILABILITY; DRUG STRUCTURE; ISOMER; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY;

ANTICOAGULANTS; BIOLOGICAL AVAILABILITY; WARFARIN; WATER;

EID: 79953689883     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.010     Document Type: Article

References (10)

1. Landefeld C., Beyth R. Anticoagulant-related bleeding - epidemiology, prediction and prevention. Am. J. Med. 1993, 95:315-328.
2. Heimark L.D., Trager W.F. The preferred solution conformation of warfarin at the active site of cytochrome P-450 based on the CD spectra in octanol/water model system. J. Med. Chem. 1984, 27:1092-1095.
3. Valente E.J., Lingafelter E.C., Porter W.R., Trager W.F. Structure of warfarin in solution. J. Med. Chem. 1977, 20:1489-1493.
4. Karlsson B.C.G., Rosengren A.M., Andersson P.O., Nicholls I.A. The spectrophysics of warfarin: implications for protein binding. J. Phys. Chem. B. 2007, 111:10520-10528.
5. Karlsson B.C.G., Rosengren A.M., Andersson P.O., Nicholls I.A. Molecular insights on the two fluorescence lifetimes displayed by warfarin from fluorescence anisotropy and molecular dynamics studies. J. Phys. Chem. B. 2009, 113:7945-7949.
6. Karlsson B.C.G., Rosengren A.M., Näslund I., Andersson P.O., Nicholls I.A. Synthetic human serum albumin Sudlow binding site I mimics. J. Med. Chem. 2010, 53:7932-7937.
7. Nicholls I.A., Karlsson B.C.G., Rosengren A.M., Henschel H. Warfarin: an environment-dependent switchable probe. J. Mol. Recognit. 2010, 23:604-608.
8. Rosengren A.M., Karlsson B.C.G., Näslund I., Andersson P.O., Nicholls I.A. In situ detection of warfarin using time-correlated single-photon counting. Biochem. Biophys. Res. Commun. 2011, 407:60-62.
9. Henschel H., Karlsson B.C.G., Rosengren A.M., Nicholls I.A. The mechanistic basis for warfarin's structural diversity and implications for its bioavailability. J. Mol. Struct. (Theochem). 2010, 958:7-9.
10. He M., Korzekwa K.R., Jones J.P., Rettie A.E., Trager W.F. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch. Biochem. Biophys. 1999, 372:16-28.